1800 202 8726
Induction chemotherapy

TPF Chemotherapy for — Head and Neck Cancer

If TPF is written on your chart, it stands for three drugs — docetaxel, cisplatin, and fluorouracil — given together before your main treatment. This page explains what the regimen is, why it is given before radiation or surgery, and what weekly cisplatin means separately.

  • Three drugs, one regimen — T is docetaxel, P is cisplatin, F is fluorouracil. Given together as induction chemotherapy before definitive treatment.
  • Comes before definitive treatment — Induction means it is the first treatment, intended to reduce the tumour before radiation or surgery begins.
  • Weekly cisplatin is separate — Weekly cisplatin is given alongside radiation — a different purpose and different timing from TPF induction.
  • High burden in this region — Head and neck cancers are among the most frequent diagnoses in Telangana and Andhra Pradesh.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

Prescription-only medicine. TPF and cisplatin-based regimens are prescription-only treatments given under the direct supervision of a specialist oncologist in an authorised hospital setting. Nothing you read here can be used to start, modify, or stop any chemotherapy regimen. Nothing on this page is a recommendation to use this medicine. It is not suitable for most patients — see "Who this is not for" below.

Ask about your own treatment

A senior medical oncologist reviews what you send and replies in writing.

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.

TPF stands for docetaxel, cisplatin, and fluorouracil — three drugs given together as induction chemotherapy before radiotherapy or surgery in locally advanced head and neck cancer. A separate cisplatin-based approach, given weekly alongside radiation, is used in a different setting. Your oncologist decides which applies based on your cancer's stage and your fitness.

What happens from first assessment to definitive treatment?

  1. Staging and fitness assessment

    Before TPF begins, your team checks kidney function, blood counts, hearing, and overall fitness. Imaging — usually a CT or PET-CT scan — establishes the extent of the disease. These results confirm whether TPF induction is the right approach for you.

  2. Induction cycles of TPF

    Docetaxel and cisplatin are given through an intravenous line. Fluorouracil follows as a continuous infusion over several days, delivered through a small portable pump you carry during that part of the cycle. Your team will train you and a family member on the pump before you leave.

  3. Recovery between cycles

    There is a rest period between cycles to allow your body — especially your blood counts — to recover. Your team monitors you during this time and checks whether the next cycle can proceed as planned.

  4. Response assessment scan

    After the planned cycles are complete, imaging shows how the tumour has responded. This is the decision point: the result determines whether you move to radiation, surgery, or concurrent chemoradiation.

  5. Definitive treatment

    Radiation, surgery, or a combination follows, based on your response assessment and your oncologist's recommendation. For many patients with locally advanced disease, this step is concurrent chemoradiation — radiation given alongside a platinum-based drug.

What is induction chemotherapy and why is it given first?

Induction chemotherapy — sometimes called neoadjuvant chemotherapy — is chemotherapy given before the main treatment, not alongside or after it.

In locally advanced head and neck cancers, the tumour is often large or involves structures that make immediate surgery or full-dose radiation difficult. Giving chemotherapy first is intended to reduce the tumour and address any early microscopic spread before definitive treatment begins.

Induction is not the same as concurrent chemotherapy, where a drug is given at the same time as radiation to strengthen its effect. These are different strategies used at different points in care.

Who this treatment is not for

TPF and cisplatin-based regimens are not appropriate for all patients with head and neck cancer. Eligibility is determined by an oncologist based on each individual's clinical situation.

  • Early-stage cancers treatable with surgery or radiation alone do not typically require induction chemotherapy.
  • Significantly reduced kidney function may prevent safe use of cisplatin, which is cleared through the kidneys.
  • Existing significant hearing loss may be worsened by cisplatin and may affect whether it can be used.
  • Established peripheral neuropathy — numbness or tingling in the hands or feet — may be worsened by docetaxel or cisplatin.
  • Cancers that have spread to distant organs are usually treated on a different pathway, not with induction TPF.
  • Poor overall fitness or organ function that cannot safely tolerate intensive multi-drug chemotherapy.

What should you prepare before each TPF cycle?

  • Bring a complete list of every medicine you take, including Ayurvedic, herbal, or over-the-counter preparations — some interact with chemotherapy drugs.
  • Tell your team about any new numbness or tingling in your hands or feet before each cycle, not at your next scheduled appointment.
  • Report any change in hearing or ringing in the ears to your team before your next cycle starts.
  • Arrange for someone to accompany you on infusion days — sessions are long and you may feel unwell afterwards.
  • Keep well-hydrated in the days around each cycle unless your team has specifically asked you to restrict fluids.
  • Do not take anti-nausea or painkiller medicines bought yourself without checking with your team first.

What does weekly cisplatin mean, and how is it different from TPF?

Weekly cisplatin is cisplatin given once a week alongside a course of radiation therapy. This is called concurrent chemoradiation, and it is distinct from TPF induction in both timing and purpose.

In concurrent chemoradiation, cisplatin acts as a radiosensitiser — it makes cancer cells more sensitive to radiation. The aim is to strengthen the effect of radiation, not to shrink the tumour before treatment begins.

Some patients receive both: TPF induction first, then concurrent cisplatin with radiation afterwards. Others receive concurrent chemoradiation without prior induction. Which approach is recommended depends on the stage, location, and biology of your cancer, and on your overall fitness.

Why are head and neck cancers so common in Telangana and Andhra Pradesh?

Oral cavity, pharyngeal, and laryngeal cancers together account for a large share of cancer diagnoses across south India. ICMR data consistently shows head and neck cancers — many associated with tobacco use, gutka, and areca nut — among the highest-burden cancers in this region.

This means regimens like TPF and cisplatin-based chemoradiation are used frequently here. Oncology teams across Telangana and Andhra Pradesh have substantial direct experience managing these treatments and their side effects.

If you or a family member has received a head and neck cancer diagnosis, you are not in unfamiliar territory for oncology centres in this part of India.

Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics

HUB — Chemotherapy Regimens

HUB — Cycles, Schedules and What Happens on Infusion Day

All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →

Common questions

Frequently asked questions

What do the letters T, P, and F actually stand for?

T is docetaxel, P is cisplatin, and F is fluorouracil, also written as 5-FU. These three drugs are given together in the TPF regimen. Docetaxel and cisplatin are given as intravenous infusions. Fluorouracil is given as a continuous infusion over several days through a portable pump. The combination is used specifically for locally advanced squamous cell cancers of the head and neck region.

How many cycles of TPF will I need?

The number of cycles is decided by your oncologist based on your response to treatment, your tolerance of the drugs, and the definitive treatment planned after induction. A short course is given before the response assessment scan. Your team will tell you the planned number at the start and may adjust it based on how you are responding and what the scans show. It is not a fixed number set in advance for every patient.

What are the main side effects I should know about?

The main side effects associated with TPF include low blood counts — which increases infection risk — nausea, mouth sores, numbness or tingling in the hands and feet, hair loss, and kidney stress from cisplatin. Hearing changes are also associated with cisplatin. Your team will monitor for all of these and will tell you which symptoms to report between appointments rather than waiting. Side effects vary considerably between individuals.

Is TPF the same as the chemotherapy given during radiation?

No. TPF is induction chemotherapy, given before radiation or surgery. The chemotherapy given alongside radiation is usually cisplatin alone, on a weekly or three-weekly schedule. The two share cisplatin as a component but are distinct regimens with different purposes, different timing, and different side-effect profiles. Your oncologist will explain which phase of the treatment plan you are in at each step.

Does TPF require hospital admission, or can it be given as day care?

The docetaxel and cisplatin infusions can often be given in a day care chemotherapy setting. The fluorouracil portion, which runs as a continuous infusion over several days, requires you to carry a portable pump and return on a scheduled day for it to be disconnected. Whether any part of your treatment needs an overnight stay depends on your overall condition and how your body responds, particularly during the first cycle.

What questions should we ask the oncologist before starting?

Ask what stage and exact type of head and neck cancer you have, and why induction chemotherapy is recommended rather than going straight to radiation or surgery. Ask how many cycles are planned, what imaging will assess the response, and what happens if the tumour does not respond as expected. Ask specifically about the risk of hearing loss and kidney effects given your current health, and ask your team to explain each drug by name and what role it plays in the regimen.

Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12